To assess whether our 3D system recapitulate the resistance of breast cancer cells to CDK4/6 inhibitors and endocrine therapy, which is associated with low FAT1 levels and Hippo pathway activation, we conducted a comparative analysis of gene expression data. This evidence concerns the gene FAT1 and breast carcinoma.